About Event  | Brochure | Registration Form | Award Nomination Form


          Platinum Partners                            Gold Partners                Delegate Kit Partner

                                                         PR & Social 
                   Media Partners            Media Partner           Knowledge Partner
Worldwide, Cancer of the Cervix is the fourth most common cancer in females. Every year cervical cancer is diagnosed in about 5,00,000 women globally and is responsible for more than 2,80,000 deaths annually. As per ICMR, Cervical Cancer is the leading cause of cancer mortality in India, accounting for 24% of all cancer deaths among women age 30 to 69 years. India accounts for one-third of the cervical deaths globally. In absolute terms, there are over 132,000 new cases of cervical cancer and nearly 74,000 deaths every year, with Indian women facing 2.5% cumulative lifetime risk and 1.4% cumulative death risk from cervical cancer.
Although primary prevention through HPV vaccination has been endorsed by WHO, under certain conditions, in low- and middle-income countries (LMICs), its cost, partial efficacy and safety have been intensely debated in India. Further research and advocacy efforts are needed to determine the optimal strategies for its introduction and sustained use in the country. However, there is considerable research and programmatic evidence in support of secondary prevention of cervical cancer through screening and treatment.  Cervical cancer is an important cause of premature death and disability among women in India. Because it primarily affects women during their most productive years when they are also caregivers, cervical cancer has adverse social and economic impacts on families and communities. Diagnosis of advanced cervical cancer is also likely to have a catastrophic economic impact on households
In view of this and to celebrate Cervical Cancer Awareness Month, ASSOCHAM is organizing National Congress on Cervical Cancer: A Race to Overcome the Killer  Disease on 18th January, 2018 at Hotel The Royal Plaza, New Delhi with an aim of advocating increased awareness on cervical cancer, reducing the stigma of people suffering and living with the disease and mobilize resources for development of policies, strategies and actions to fight the disease.

Registration Fees: 

  • Delegate Registration Fee : Rs. 3,000/- per delegate (GST will be applicable @ 18%)